These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25210616)

  • 1. Nigrostriatal dynein changes in A53T alpha-synuclein transgenic mice.
    Liu Y; Yuan YH; Sun JD; Li J; Li ZP; Chen NH
    F1000Res; 2014; 3():68. PubMed ID: 25210616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of Motor Performance and Nigrostriatal Dopamine Cell Volume Using a Novel Far-Infrared Ceramic Blanket in an A53T Alpha-Synuclein Transgenic Parkinson's Disease Mouse Model.
    Carrick FR; Hernandez LSAV; Sugaya K
    Curr Issues Mol Biol; 2023 Dec; 45(12):9823-9837. PubMed ID: 38132459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The increase of α-synuclein and alterations of dynein in A53T transgenic and aging mouse.
    Wang Y; Sun Z; Du S; Wei H; Li X; Li X; Shen J; Chen X; Cai Z
    J Clin Neurosci; 2022 Feb; 96():154-162. PubMed ID: 34810061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Icariin Inhibits Overexpression and Aggregation of α-Synuclein in A53T α-Synuclein Transgenic Mice by Regulating Parkin and PLK2.
    Ma D; Shen C; Zhang X; Zhang L; Li L
    J Integr Neurosci; 2023 Nov; 22(6):166. PubMed ID: 38176950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice.
    Wu Q; Yang X; Zhang Y; Zhang L; Feng L
    Exp Neurol; 2016 Nov; 285(Pt A):61-71. PubMed ID: 27637804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A53T-alpha-synuclein-overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAP.
    Kurz A; May C; Schmidt O; Müller T; Stephan C; Meyer HE; Gispert S; Auburger G; Marcus K
    J Neural Transm (Vienna); 2012 Mar; 119(3):297-312. PubMed ID: 21960009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function.
    Oaks AW; Frankfurt M; Finkelstein DI; Sidhu A
    PLoS One; 2013; 8(4):e60378. PubMed ID: 23560093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model.
    Wang W; Song N; Jia F; Tang T; Bao W; Zuo C; Xie J; Jiang H
    Neurochem Int; 2018 Mar; 114():71-79. PubMed ID: 29355568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression.
    Bourdenx M; Dovero S; Engeln M; Bido S; Bastide MF; Dutheil N; Vollenweider I; Baud L; Piron C; Grouthier V; Boraud T; Porras G; Li Q; Baekelandt V; Scheller D; Michel A; Fernagut PO; Georges F; Courtine G; Bezard E; Dehay B
    Acta Neuropathol Commun; 2015 Jul; 3():46. PubMed ID: 26205255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Dietary Iron Supplement Induces the Nigrostriatal Dopaminergic Neurons Lesion in Transgenic Mice Expressing Mutant A53T Human Alpha-Synuclein.
    Jia F; Song N; Wang W; Du X; Chi Y; Jiang H
    Front Aging Neurosci; 2018; 10():97. PubMed ID: 29681846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender Differences in Neurodegeneration, Neuroinflammation and Na
    Costa G; Sisalli MJ; Simola N; Della Notte S; Casu MA; Serra M; Pinna A; Feliciello A; Annunziato L; Scorziello A; Morelli M
    Front Aging Neurosci; 2020; 12():118. PubMed ID: 32477098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.
    Oliveras-Salvá M; Van der Perren A; Casadei N; Stroobants S; Nuber S; D'Hooge R; Van den Haute C; Baekelandt V
    Mol Neurodegener; 2013 Nov; 8():44. PubMed ID: 24267638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzo(a)pyrene exposure in utero exacerbates Parkinson's Disease (PD)-like α-synucleinopathy in A53T human alpha-synuclein transgenic mice.
    Xu W; Qi Y; Gao Y; Quan H; Li Q; Zhou H; Huang J
    Toxicol Appl Pharmacol; 2021 Sep; 427():115658. PubMed ID: 34332006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-motor parkinsonian pathology in aging A53T α-synuclein mice is associated with progressive synucleinopathy and altered enzymatic function.
    Farrell KF; Krishnamachari S; Villanueva E; Lou H; Alerte TN; Peet E; Drolet RE; Perez RG
    J Neurochem; 2014 Feb; 128(4):536-46. PubMed ID: 24117685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.
    Martin LJ; Pan Y; Price AC; Sterling W; Copeland NG; Jenkins NA; Price DL; Lee MK
    J Neurosci; 2006 Jan; 26(1):41-50. PubMed ID: 16399671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegeneration and contralateral α-synuclein induction after intracerebral α-synuclein injections in the anterior olfactory nucleus of a Parkinson's disease A53T mouse model.
    Flores-Cuadrado A; Saiz-Sanchez D; Mohedano-Moriano A; Martinez-Marcos A; Ubeda-Bañon I
    Acta Neuropathol Commun; 2019 Apr; 7(1):56. PubMed ID: 30987677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons.
    Daher JP; Ying M; Banerjee R; McDonald RS; Hahn MD; Yang L; Flint Beal M; Thomas B; Dawson VL; Dawson TM; Moore DJ
    Mol Neurodegener; 2009 Jul; 4():34. PubMed ID: 19630976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.